Justifying Re-Test Periods with Stability Data
Re-test periods form a critical part of pharmaceutical quality systems, particularly for APIs and intermediates. These durations define the timeframe during which materials remain within specification when stored under defined conditions. However, assigning a re-test period without scientific backing can lead to non-compliance, quality failures, or regulatory citations. In this tutorial, we’ll explore how to…
Read More “Justifying Re-Test Periods with Stability Data” »